Ultrahuman has raised $60.0M in a Series C round, with Qualcomm Ventures providing the capital. The funding lands as the company pushes deeper into its pitch: a full-stack approach to self-quantification that spans wearables, glucose monitoring, home sensors, and blood testing.
The company’s lineup includes the Ultrahuman Ring AIR, a sleep-tracking wearable, alongside the M1 continuous glucose monitor, the Home device for tracking environmental factors like air quality and light exposure, and Blood Vision, a preventive testing platform. The idea is to pull data from multiple sources-sleep, movement, glucose, even your living room-and stitch it together into a clearer picture of metabolic and overall health. Qualcomm Ventures’ backing signals interest in the hardware-plus-data model, though the company hasn’t detailed how the fresh capital will be deployed.
